Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorMatthew R. Janes, Jose J. Limon, Lomon So et al.|Nature Medicine|2010Cited by 338
mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibitionJose J. Limon|Proceedings of the National Academy of Sciences|2014Cited by 75